Investigation of Milk Peptides (Pep2Dia®) on Postprandial Blood Glucose Profile in Prediabetic Subjects

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2020
The goal is to investigate the 180 min postprandial response on blood glucose and insulin levels after intake of Pep2Dia® in two different dosages compared to placebo in the context of a meal challenge test, providing 75 g of carbohydrates. Pep2Dia® will be administered 15 min prior to a standardized challenge meal.
Epistemonikos ID: 4907df4b5630d61dfc2c152fabb54c78104024d1
First added on: May 07, 2024